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ABSTRACT 
Exercise training (“exercise”) and hypocaloric diet (“diet”) are frequently prescribed for 
weight loss in obesity. Whilst body weight changes are commonly used to evaluate lifestyle 
interventions, visceral adiposity (VAT) is a more relevant and stronger predictor for morbidity 
and mortality. We performed a meta-analysis to assess the effects of exercise training or 
hypocaloric diet on VAT (quantified by radiographic imaging). Relevant databases were 
searched through May 2014. 117 Studies (n=4,815) were included. We found that both 
exercise and diet cause VAT loss (P<0.0001). When comparing diet versus training, diet 
caused a larger weight loss (P=0.04). In contrast, a trend was observed towards a larger VAT 
decrease in exercise (P=0.08). Changes in weight and VAT showed a strong correlation after 
diet (R²=0.737, P<0.001), and a modest correlation after exercise (R²=0.451, P<0.001). In the 
absence of weight loss, exercise is related to 6.1% decrease in VAT, whilst diet showed 
virtually no change (1.1%). In conclusion, both exercise and diet reduce VAT. Despite a 
larger effect of diet on total body weight loss, exercise tends to have superior effects in 
reducing VAT. Finally, total body weight loss does not necessarily reflect changes in VAT 
and may represent a poor marker when evaluating benefits of lifestyle-interventions. 
 
Keywords: obesity, visceral adipose tissue, exercise training, hypocaloric diet 
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INTRODUCTION 
The worldwide prevalence of obesity, characterized by an excess in adipose tissue, has grown 
to pandemic proportions.1, 2 Multiple reviews have demonstrated that accumulation of adipose 
tissue in general, and in the visceral area in particular, is strongly and positively correlated 
with all-cause morbidity and mortality.3 Since obesity is an important, but also modifiable, 
risk factor for cardiovascular and metabolic diseases 4, 5 the WHO has recommended lifestyle 
interventions to aim at 5-10% reduction in body weight as treatment for obesity.6 
  
Caloric restriction and exercise training cause a reduction in body weight by inducing a 
negative energy balance in which energy expenditure exceeds caloric intake. When 
comparing hypocaloric diet and exercise training, previous meta-analyses revealed that 
dietary restriction has superior effects on weight reduction.7, 8 However, a growing body of 
evidence shows that excess visceral adipose tissue (VAT) may result in more detrimental 
obesity-related health effects than excess body weight.9 Indeed, increased VAT is strongly 
associated with insulin resistance, atherogenic dyslipidemia, and cardiovascular disease.3, 10, 11 
Moreover, a reduction in VAT improves cardiovascular and metabolic risk.3, 12 Hence, 
changing VAT is considered to be more important than weight reduction in the management 
of obesity.  
 
In patients with obesity, physical exercise training leads to a healthier metabolic and 
cardiovascular phenotype.13-15 Whilst exercise training does not always aim to reduce body 
weight, exercise training in general and aerobic exercise training in particular, have potent 
effects on reducing VAT.16-18 Previous meta-analyses have evaluated only the effects of 
caloric restriction and aerobic exercise on weight loss. The effects of these interventions on 
VAT have not yet been compared. Therefore, we aim to conduct a systematic review and 
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meta-analysis to investigate the effect of caloric restriction versus aerobic exercise training on 
visceral adiposity loss in overweight and obese adults. For this purpose, we included studies 
that examined VAT after: 1. Caloric restriction only, 2. Exercise training only, and 3. Aerobic 
exercise training versus caloric restriction. We hypothesize that, in marked contrast to body 
weight loss, caloric restriction and exercise training have comparable effects on reducing 
VAT. With the use of a meta-regression analysis we aim to further explore the impact of 
intervention (e.g. duration, intensity, frequency) and subject (e.g. age, sex, baseline body 
weight) characteristics on the magnitude of changes in VAT.  
 
Several international guidelines recommend lifestyle interventions aimed at a reduction in 
body weight of 5-10% as treatment for obesity.6, 19, 20 Previous work, however, demonstrated 
that a reduction in body weight is a poor marker for VAT change.9 Accordingly, changes in 
VAT may occur irrespective of changes in body weight. A hypocaloric diet causes a reduction 
in skeletal muscle mass, which along with a reduction in fat mass, contributes to weight 
loss.21, 22 Aerobic exercise training, however, may be associated with an increase in lean body 
mass and/or plasma volume.23-25 Assuming that fat mass decreases with exercise training, 
training may still not lead to weight loss 24, 26 Therefore, we hypothesize that the relation 
between changes in body weight and changes in VAT differs between caloric restriction and 
exercise interventions.  
 
 
METHODS 
Data sources and searches 
The systematic literature search and documentation of literature was performed with the use 
of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) 
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statement .27  Databases systematically searched were Pubmed, Cochrane, Web of Science 
and Embase. The following search strategy was used, with adaption for each database: 
(("Energy Intake"OR"Diet Therapy"OR"(calori*AND restrict*)"OR(low AND 
calori*)OR"dietary intervention*"OR"diet intervention*)"AND 
("Overweight"OR"obes*")AND("Abdominal Fat"OR("Adipose Tissue"AND("intra-
abdom"*ORintraabdom*ORabdom*ORvisceral*))OR"Body Composition"OR"abdominal 
adipos*ORvisceral adipos*ORintra-abdominal fat"OR"abdominal fat"OR"total body 
fat"OR"adipose tissue distribution))OR(("Overweight"OR"obes*")AND("Motor 
Activity”OR"Exercise"OR"Running"OR"Swimming"OR"Walking"OR"Warm-Up 
Exercise"OR"Exercise Therapy"OR"Motion Therapy, Continuous Passive"OR"Sports”OR 
"Athletic Performance"OR"Bicycling"OR"Physical Exertion"OR"running" 
OR"bicycling"OR"cycling"OR"walking"OR"swimming"OR"training"OR"physical 
activity"OR"exercis*"OR"cardio-training")AND("Abdominal Fat"OR("Adipose Tissue" 
AND (intra-abdom*OR"intraabdom*"OR"abdom*"OR"visceral*"))OR"Body Composition" 
OR"abdominal adipos"*OR"visceral adipos"*OR"intra-abdominal fat"OR"abdominal 
fat"OR"total body fat"OR"adipose tissue distribution")). Randomized Controlled Trials 
(RCTs), Non-randomized Controlled Trials (non-RCTs) OR Clinical Trials (CT) published in 
English, German and Dutch were included from January 1th, 1987 to May 5th, 2014. 
Reference lists of included articles were manually checked by RV for possible eligible studies 
that were missed during the literature search (Figure 1). This represents a valid and frequently 
used method to further increase the number of potentially eligible studies.  
 
Study selection 
To standardize the selection procedure by two independent reviewers, investigators received 
the local review protocol previous to the selection of studies,. After the elimination of 
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duplicates, one investigator (RV) screened study titles for eligibility with use of the in- and 
exclusion criteria in the review protocol, which are listed below. Two reviewers (RV, MM) 
independently screened the abstracts of the remaining studies. 389 studies were assessed in 
full text (Figure 1). Inter-reviewer disagreements were resolved through consensus or by 
consulting a third reviewer (MH). When study characteristics or viable information was 
missing, an attempt was made to request missing information from the authors by email (n=6 
studies; authors of n=2 studies provided requested information). Studies were included when 
the mean age at entry was ≥18 years and mean BMI was ≥25 kg/m². Studies of HIV-infected 
individuals were excluded because of the interference of anti-retroviral drugs with abdominal 
adipose tissue.16 Because spinal cord injuries associated with changes in body composition, 
studies conducted in spinal cord injured individuals  were also excluded.28 Studies with one or 
more arms assigned to an aerobic exercise intervention or a hypocaloric diet were eligible for 
inclusion. For the first aim, Clinical Trials and Randomized Controlled Trials (RCTs) with 
one arm assigned to exercise or caloric restriction were selected. Furthermore, in order to 
directly compare duration- and energy deficit- matched exercise training with caloric 
restriction, RCT’s with an exercise- and a diet-arm were included. To identify exercise and 
subject characteristics that predict the magnitude of change in VAT using the meta-regression 
analysis, clinical trials and RCT’s with one arm assigned to exercise or caloric restriction 
were selected. Finally, diet and exercise studies that provided baseline and post-intervention 
results for VAT and weight were included for the correlation analysis. Exercise training was 
defined as a program including voluntary aerobic exercise at a low to vigorous intensity for at 
least two times per week during a minimum period of four weeks and with a minimum 
duration of 20 minutes per session. Caloric restriction was defined as a daily reduction in 
energy (caloric) intake of at least 10% of the habitual intake (2000 kcal for women, 2500 kcal 
for men) during a minimum period of four weeks. Interventions combining exercise and diet 
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therapy or adding resistance exercise or bariatric surgery to an intervention arm were 
excluded. Studies in which a pharmacological dietary supplement was used were excluded 
from our analysis. Studies were eligible when VAT was measured with the use of 
Computerized Tomography (CT) or Magnetic Resonance Imaging (MRI). which are both 
considered to be the gold standard for the quantitative measurement of VAT29. Studies that 
used another measurement technique were excluded. 
 
Data extraction and Quality assessment  
Baseline and post-intervention mean VAT area or volume and standard deviation or standard 
error was independently recorded by two authors (RV, MM). When VAT was measured at 
multiple sites, the measurement at the 4th and/or 5th lumbar vertebrae was recorded for further 
analysis, since this region is most strongly correlated with body adiposity.28 Based on changes 
in visceral abdominal fat area or volume, percentage change in VAT for each study was 
calculated by one of the authors (RV) for the correlation analysis. Percentage weight loss was 
also calculated based on pre- and post-intervention values. Furthermore, publication year, 
journal, study design, sample size, age, sex, weight, BMI, and intervention details (duration, 
intensity and frequency (exercise studies), caloric deficit (diet studies) were extracted from all 
included studies. When results were depicted in figures only (n=14 studies), data were 
extracted with the use of GetData Graph Digitizer. A request by email was send to the 
authors, when key information was not included in the published manuscript (n=6 studies). 
Two out of six authors responded to our repeated email requests, thus the remaining 4 studies 
were excluded from further analysis. 
 
The quality of each eligible study was independently assessed by two authors (RV and MM), 
with the use of a modified version of The Critical Review Form for Quantitative Studies, from 
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Law et al.30. One item (“contamination was avoided”) was not applicable for the studies 
included in this meta-analysis and was therefore removed for analysis. Only studies with a 
minimum score of 10 out of 14 items were eligible for inclusion (Figure 1).  
 
Data synthesis and analysis 
To account for potential heterogeneity between studies, a random-effects model (specified a 
priori) was used to determine the overall effect size of the intervention (exercise training or 
hypocaloric diet) on VAT. Effect sizes for RCTs and clinical trials were calculated as the 
standardized mean difference (SMD) with corresponding 95%-CI. A correlation of 0.5 
between the outcomes measured in each study arm (i.e. exercise, diet, or control) was 
assumed. When a study contained multiple study arms, all were included in the statistical 
analysis, whereby the different intervention groups were individually compared against the 
control group. Analyses to assess the following comparisons: (1) diet versus control; (2) 
exercise versus control; (3) diet versus exercise were performed. The Cochrane’s Q statistic 
and I² were calculated to assess the degree of heterogeneity across studies. Publication bias 
was assessed using visual analysis of the funnel plot asymmetry using the ‘trim and fill’ and 
the ‘Classic fail ‘n safe’ algorithms. All calculations and plots were performed in CMA-2 
(Comprehensive Meta-Analysis 2nd version, Biostat, Englewood, NJ, USA). 
 
Meta-regression analysis 
To assess the effects of subject and intervention characteristics on VAT loss, random-effects 
meta-regression analysis with SMD as dependent variable was calculated. The weighted 
inverse variance (with correction for total n) was used as weight factor. For the purpose of 
meta-regression analysis, the aerobic exercise arms (n=86) were separated from the 
hypocaloric diet arms (n=87). In both study types, duration of the exercise training or diet 
Verheggen et al.   9 
 
intervention (weeks), measurement technique (CT or MRI), body weight at baseline, age and 
sex were defined as a covariate. Duration was assessed as a categorical variable (duration <16 
weeks versus duration of ≥16 weeks). In the exercise studies, intensity of the intervention was 
examined as a covariate. Intensity was categorized in ‘vigourous intensity’ (i.e. largely 
performed at 70% of maximal heart rate (maxHR) or >55% of maximal oxygen uptake 
(VO2max) or 60-80% of the heart rate reserve (HRR)), ‘moderate intensity’ (60-70% of 
maxHR, 45-55% of VO2max or at the lactate threshold), and ‘low intensity’ (<60% of 
HRmax or <45% of VO2max) based on previous work.18 This categorization is somewhat 
different from the often used and more practical categories based on METs as proposed in the 
ACSM and AHA guidelines.31, 32 However, only two studies included in our meta-analysis 
provided data on METs. Since translating percentages of maximum heart rate, heart rate 
reserve and VO2max into METs proves difficult with the use of average data on group level, 
we adopted the aforementioned strategy to divide studies based on intensity.  In hypocaloric 
diet studies, “intensity” was divided in ‘very low calorie diets’ (VLCDs; reduction to maximal 
800 kcal/day) and ‘low calorie diets (LCDs; caloric restriction to 800-2000 kcal/day). Lastly, 
frequency (times spent in training per week) was added as covariate in exercise studies.  
 
Correlation analysis 
 To examine correlations between weight loss and VAT improvement a Pearson correlation 
coefficient was calculated. The formula of the corresponding trend line was retrieved with the 
use of linear regression. Meta-regression analyses and correlation analysis were conducted 
with use of SPSS version 20.0. 
 
RESULTS 
Selection of studies for the meta-analysis 
Verheggen et al.   10 
 
The original search resulted in 15,964 studies. Eleven more studies were found from the 
reference lists of the included full text papers. After removal of duplicates and elimination of 
papers based on the eligibility criteria and quality assessment, 50 aerobic exercise studies and 
59 hypocaloric diet studies were included (Figure 1). For the analysis of a direct comparison 
between caloric restriction and exercise training, 8 studies were included. (Table 1) One 
study, which directly compared exercise training with caloric restriction was excluded as 
duration and energy deficit did not match between the two intervention arms. This study was 
included for the separate analysis of diet or exercise training only. 
 
Cohort characteristics 
A total number of 4,815 individuals (2,404 in the exercise studies, 2,411 in the hypocaloric 
diet studies) participated in the interventions. (Table 1) In the 8 RCT’s that directly compared 
exercise training and caloric restriction, a total of 400 individuals were included (200 in the 
exercise arm, 200 in the diet arm). (Table 2) 28 studies exclusively included male subjects, 
whereas in 39 studies females were exclusively included. 55 studies included both sexes. 
Some studies recruited specific populations, which included older (aged 50-80 years) 
individuals (n=4); patients with type 2 diabetes (n=11), impaired glucose tolerance (n=3) and 
metabolic syndrome (n=3). (Table 1) 
 
Meta-analysis 
The SMD of change in VAT after exercise training was -0.47 (95%CI -0.56 to -0.39, 
P<0.0001). (Figure S1) Heterogeneity analysis showed significant heterogeneity (Cochran’s 
Q=265.4; I²=68.0). Through a funnel plot of standard error by Hedge’s g and the Trim ‘n Fill 
algorithm, publication bias was assessed. With the use of the Classic Fail ‘n Safe approach, it 
became clear that there was no significant publication bias since 7427 missing studies would 
Verheggen et al.   11 
 
be required to achieve a p-value above 0.05. The SMD of change in VAT after caloric 
restriction was –0.63 (95%CI -0.71 to -0.55, P<0.0001) (Figure S2), whilst significant 
heterogeneity was present (Cochran’s Q= 236.0; I²= 63.6). In these studies, no publication 
bias was present since there would be 4096 studies required to achieve a p-value above 0.05. 
Based on the studies that directly compared exercise training and caloric restriction, exercise 
training caused a non-significantly larger decrease in VAT (-0.59, 95%CI -1.248 to 0.071; 
P=0.08), whilst caloric restriction caused a significantly larger weight loss than exercise 
training (SMD 0.308, 95%CI 0.02 to 0.60; P=0.04) (Figure 2). Heterogeneity analysis showed 
significant heterogeneity (Cochran’s Q=51.9; I²=86.5). Publication bias was assessed with the 
Trim ‘n Fill method and showed no change in SMD when adding trimmed studies, for both 
the weight loss as VAT loss data. 
 
Meta-regression analysis 
No effect of measurement technique on the SMD was observed for studies that performed 
exercise training or diet (data not shown). In the exercise studies, univariate analysis revealed 
that the SMD for VAT improvement was significantly influenced by sex (R²=0.11; 95%CI 
0.06 – 0.472; P=0.012); duration (R²=0.073; 95%CI -0.449 to -0.055; P=0.013) and frequency 
(R²=0.084; 95%CI -0.157 to -0.030; P=0.004). The multivariate regression analysis, which 
included the factors that revealed a significant impact in the univariate analysis, identified an 
impact of male sex on SMD (R²=0.20; 95%CI 0.066 to 0.467; P=0.01). In hypocaloric diet 
studies, univariate analysis showed a significant effect of male sex only (R²=0.09; 95%CI 
0.116 to 0.632; P=0.005). 
 
Correlation analysis 
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For exercise studies, a moderate correlation was found between changes in weight versus 
changes in VAT after exercise training (R²=0.453, P<0.001), whilst diet-interventions showed 
a strong correlation between the change in weight versus change in VAT (R²=0.737, P<0.001) 
after caloric restriction. Exercise training showed a somewhat steeper slope compared to diet 
(-3.04x versus -2.41x, respectively), and a larger Y-axis intercept (-6.1 versus -1.1, 
respectively, Figure 3). 
 
DISCUSSION 
The present work is the first meta-analysis to compare the effect of caloric restriction and 
aerobic exercise training on visceral adipose tissue (VAT) loss in overweight and obese 
individuals. We present the following findings. First, our results confirm that both caloric 
restriction and exercise training successfully reduce VAT. Second, in studies that provided a 
direct comparison of caloric restriction and exercise training, a hypocaloric diet resulted in 
significantly larger weight loss. Interestingly, these studies reveal a different story for VAT. 
Exercise training tends to show a larger decrease in VAT compared to caloric restriction. The 
distinct effects of both interventions on total body weight and VAT are supported by the 
correlation analysis. Only a moderate correlation was found for the exercise training cohort 
between changes in weight and VAT. Furthermore, in the absence of weight loss, exercise 
training results in a 6.1% decrease in VAT, whilst a hypocaloric diet leads to virtually no 
change (1.1%). This suggests that evaluating only total body weight changes could lead to 
spurious conclusions when evaluating the efficacy of a lifestyle intervention in overweight 
and obese individuals since health benefits occur independent of body weight changes. 
Indeed, even in the absence of weight loss after exercise training, health benefits such as a 
reduction in VAT are present. 
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In line with previous meta-analyses, we found caloric restriction to have a larger effect on 
weight loss than exercise training.7, 8 We extended this finding by a direct comparison of 
studies with matched duration and energy deficit in order to more accurately compare the 
impact of both interventions. In marked contrast to the superior effect of caloric restriction on 
weight loss, no difference in VAT reduction was observed between caloric restriction and 
exercise training. In fact, exercise training tended to have a superior effect on VAT reduction 
compared to caloric restriction. A possible mechanism underlying these different effects on 
weight and VAT could relate to distinct changes in body composition during these lifestyle 
interventions. During caloric restriction, both muscle mass and fat mass are lost, resulting in a 
marked decline in weight.21, 22 During exercise training, however, lean body mass and 
circulating plasma volume increase, whilst fat mass decreases.21, 23, 25, 26, 33 Previous work that 
directly measured these factors indeed showed that an increase in lean body mass counteracts 
loss of fat mass after 8 weeks of exercise training.34 These opposing effects resulted in the 
absence of total body weight loss.34 Appreciating and understanding these effects are 
important to acknowledge that exercise training effectively reduces VAT, despite the absence 
of a reduction in body weight. 
 
In this meta-analysis, a large number of studies were included. Multivariate meta-regression 
analysis on these data showed that male sex is associated with a larger decrease in VAT, in 
both exercise and diet interventions. Other subject and intervention characteristics did not 
influence the magnitude of VAT loss in the multivariate model. A possible explanation that 
underlies the larger effect of lifestyle interventions on VAT in men is that men typically have 
larger VAT stores than women. As a result, this makes male participants more likely to lose 
VAT than female partcipants.35 However, our meta-regression analysis showed no effect of 
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baseline VAT area on the magnitude of VAT decrease. The exact underlying mechanisms 
should be subject for future research. 
 
The distinct effects of diet and exercise training on weight and VAT suggest the presence of a 
different correlation between changes in body weight and VAT after caloric restriction in 
comparison to exercise training. Indeed, whilst a strong correlation between changes in body 
weight and VAT was found after caloric restriction, this correlation was only moderate for 
exercise training studies. This means that a change in weight after hypocaloric diet predicts a 
substantial effect on VAT, whereas changes in weight after exercise training only modestly 
predict the change in VAT. Furthermore, the trend lines for these correlations show important 
differences. The Y-intercept for the correlation of exercise studies is 6.1%, meaning that the 
absence of weight loss after exercise training is still correlated with a significant and 
meaningful reduction in VAT of 6.1%. In marked contrast, studies examining the impact of 
hypocaloric diet revealed a Y-intercept of only 1.1%, which means that in the absence of 
weight loss only 1.1% of VAT is lost. Furthermore, the steepness of the correlation for 
exercise training is slightly higher than that observed after hypocaloric diet. Taken together, 
these data strongly indicate that a change in weight, which is currently recommended by 
international guidelines for the management of obesity, does not necessarily reflect changes in 
VAT. 
 
Limitations 
The presence of heterogeneity of the included studies may represent a potential limitation 
when interpreting the results of this review. However, to correct for this heterogeneity a 
random effect approach was selected to perform the meta-analyses, which was specified a 
priori. Furthermore, analysis of publication bias with use of the Classic Fail ‘n Safe method 
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showed that an unrealistically large number of studies is needed to influence the significant 
results obtained in our meta-analyses. Therefore, we are confident that the heterogeneity 
observed in the studies included in this analysis does not impact the major conclusions of our 
study. Another limitation might be that information about the ethnicity of participants in the 
included studies is lacking. Often, this information was not available in the original papers. 
However, we included studies that were conducted on all different continents, with exception 
for the African continent. We therefore believe that this meta-analysis provides conclusions 
applicable for every ethnic group. 
 
Clinical relevance 
As treatment for obesity, international guidelines including WHO and ACSM guidelines, 
recommend a minimum of 5% loss of body weight loss.4, 6, 20 Although in common clinical 
practice a combination of training and hypocaloric diet is often prescribed, it is highly 
relevant to understand the separate effects of these interventions. Indeed, our study reveals 
that effects on weight loss and VAT loss are different in training and diet interventions. For 
example, a 5% reduction in body weight after hypocaloric diet has a different effect on VAT 
than a similar reduction in body weight after exercise training. Indeed, 5% loss in body weight 
is associated with 21.3% reduction in VAT after exercise training, but only with 13.4% 
reduction in VAT after a hypocaloric diet. To reduce VAT by 13.4% after exercise training, 
weight loss of only 2.4% is needed. Moreover, the absence of a reduction in body weight after 
exercise training may lead physicians to incorrectly conclude that the intervention has failed. 
This is in accordance with the ACSM position statement on appropriate physical intervention 
strategies for weight loss, which also emphasized that exercise training entails health benefits 
in the absence of weight loss.20 In fact, it is likely that a clinically relevant VAT reduction (of 
6.1%) is present in the absence of weight loss after exercise training, which may lead to 
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reductions in cardiovascular risk and improvement in metabolic health. Therefore, it seems 
incorrect to recommend a 5% weight loss for all lifestyle interventions. 
 
In conclusion, our systematic review and meta-analysis provide evidence that exercise 
training, despite smaller effects on reducing body weight, tends to have superior effects on 
reducing visceral adipose tissue compared to diet interventions in overweight and obese 
subjects. This suggests that changes in body weight represent a poor marker for adaptation in 
visceral adipose tissue, especially when performing exercise training. Our data therefore 
strongly indicate that, in clinical practice, caution should be taken when interpreting (lack in) 
changes of body weight after exercise training interventions. Incorrect conclusions can 
potentially lead to recommendations or suggestions that the exercise intervention was 
unsuccessful, despite the presence of a marked effect on body composition. Setting the correct 
targets for evaluating the health benefits of lifestyle interventions is therefore recommended.  
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Supporting Information: 
Figure S1. Forest plot of the effect size (SMD) of exercise training on VAT loss. The effect 
size (SMD) and 95% CI for individual studies and the pooled estimate (assessed with the use 
of Random Effects Model) are depicted. 
 
Figure S2. Forest plot of the effect size (SMD) of hypocaloric diet on VAT loss. The effect 
size (SMD) and 95% CI for individual studies and the pooled estimate (assessed with the use 
of Random Effects Model) are depicted. 
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FIGURE LEGENDS 
FIGURE 1. PRISM Flowchart of outcomes of search strategy 
 
FIGURE 2. Forest plot of the effect size (SMD) of (A) exercise training versus caloric  
restriction on weight loss and (B) exercise training versus caloric restriction on VAT loss. The  
effect size (SMD) and 95%CI for individual studies and the pooled estimate (assessed with  
the use of Random Effects Model) are depicted. 
 
FIGURE 3. Correlation between %VAT improvement and %weight loss for exercise studies  
(R²=0.4531, P<0.001; trendline: y = -3.03x – 6.1),  and caloric restriction studies (R²=0.737,  
P<0.001; trendline: y = -2.46x - 1.1).  
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Table 1 Overview of the characteristics of the included Exercise training (n=50) and Hypocaloric diet (n=59) studies. 
Exercise Training Studies 
Reference Groups N (M/F) Age (years) BMI 
(kg/m²) 
Intensity Frequency/ 
duration per 
session  
Dura-  
tion 
(weeks) 
Assess-
ment 
VAT 
Results VAT 
(pre / post) 
Weight (kg) 
(pre/post) 
Baria et 
al.36 
 
 
Centre-based 
exercise 
Home-based 
exercise  
Control  
10 (10/0) 
 
8 (8/0) 
 
10 (10/0) 
52.1 ± 11.4 
 
50.8 ± 7.7 
 
53.4 ± 9.6 
30.8 ± 5.1 
 
30.9 ± 3.9 
 
29. ± 1.9 
Personal ventilatory 
treshold 
 
3x/week /  
30-60min 
12 CT L4-L5 
(mm) 
113.1 ± 24.1 / 
106.6 ± 22.8 
115.2 ± 20.5 / 
107.4 ± 17.0 
92.1 ± 25.9 / 
97.0 ± 23.9 
86.2 ± 19.4 / 
86,1 ± 20.7 
90.9 ± 12.4 / 
89.3 ± 11.9 
84.8 ± 7.8 / 
+1.5kg 
Boudou et 
al.37 
 
 
Exercise  
 
 
Control  
8 (8/0) 
 
 
8 (8/0) 
42.9 ± 5.2 
 
 
47.9±8.35 
28.3 ± 3.9 
 
 
30.85±5.2  
75% of VO2peak & 
5 x 2 min 85% of 
VO2peak 
alternated by 3x 
50% of VO2peak 
2x/week / 45 
min & 1x/week 
/ 19 min 
8 MRI L4-
L5 (cm²) 
153.25± 38.55/  
84.20±21.30 
 
156.85±23.40 / 
150.35±23.3 
86.90 ± 13.4/ 
85.00 ±13.8 
 
85 ± 13.75 / 
88.75 ± 1.30 
Cho et 
al.38 
 
 
Low-intensity 
exercise  
High-intensity 
exercise  
Control  
15 (0/15) 
 
15 (0/15) 
 
15 (0/15) 
42.4 ± 7.6 
 
45.6 ± 4.6 
 
49.2 ± 8.7 
25. 6 ± 1.7 
 
25.1 ± 2.0 
 
26.1 ± 2.7 
40-50% of VO2max 
70-75% of VO2max 
3/week ( 
duration 
depending on 
energy 
expenditure) 
12 CT L4-L5 
(cm²) 
99 ± 41 /  
79 ± 40 
90 ± 26 /  
83 ± 30 
106 ± 33 / 
103 ±28 
64.4 ± 6.0 /  
62.3 ± 5.5 
63.2 ± 6.4 / 
60.4 ± 6.4 
63.0 ± 7.8 /  
64.5 ± 7.0 
Cuff et 
al.39 
 
Aerobic exercise  
 
Control  
9 (0/9) 
 
9 (0/9) 
59.4 ± 1.9 
 
60.0 ± 2.9 
32.5 ± 1.4 
 
36.7 ± 2.0 
60-75% maxHR 3x /week / 75 
min 
16 CT L4-L5 
(cm²) 
215.7 (25.8) /  
-8.8 (5.4) 
225.8 (8.9) / 
 - 0.4 (12.0 
81.2 ± 3.8 / 
 -1.2 (0.7) 
95.6 ± 6.5 /  
+2.0 (1.2) 
Davidson 
et al.40 
Aerobic exercise  
 
Control  
37 (17/20) 
 
28 (11/17) 
 
68.8±6.0(m) 
69.1±6.5 (f) 
67.4±3.8(m) 
66.7 ± 3.7(f) 
29.9 ± 3.0 
29.2 ± 3.7 
30.5 ± 2.0 
30.4 ± 3.2 
60-75% of 
VO2peak 
 
 
7x/week / 30 
min 
26 MRI (kg) -11.0 (1.9)% 
 
-0.7 (2.5)% 
 
NR / -2.7 
(3.1)% 
NR / -0.1 
(0.7)% 
Dekker et 
al.41 
Obese with T2D  
 
Obese  
8 (8/0) 
 
8 (8/0) 
51.0 ( 3.0) 
 
47.1 (3.1) 
29.9 (1.2) 
 
32.4 (0.6) 
60% VO2max 
 
5x/week / 60 
min 
12 MRI L4-
L5 (kg) 
3.8 (0.3) / 3.1(0.4) 
 
4.0 (0.4) /3.4 (0.4) 
93.5 (2.9) / 
93.9 (3.2) 
97.6 (3.4) / 
97.2 (0.6) 
Despres et 
al.42 
Aerobic exercise  13 (0/13) 38.8 ± 5.3 34.5 ± 4.3 55% of VO2max 4-5x/week /  
90 min 
12 CT L4-L5 
(cm²) 
124.7 ± 48.6 / 
121.3 ± 45.5 
90.0 ± 11.8 /  
86.3 ± 9.6 
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Reference Groups N (M/F) Age (years) BMI 
(kg/m²) 
Intensity Frequency/ 
duration per 
session  
Dura-  
tion 
(weeks) 
Assess-
ment 
VAT 
Results VAT 
(pre / post) 
Weight (kg) 
(pre/post) 
Dipietro et 
al.43 
 
Aerobic exercise  
 
 
 
Control  
9 (2/7) 
 
 
 
7 (1/6) 
72 (1) 
 
 
 
73 (1) 
27.5 (2.7) 
 
 
 
26.8 (1.5) 
55% of maxHR 
during 1 month 
75% during 3 
months 
4x/week /  
40-60min 
17 CT L4-L5 
(cm²) 
116 (31) /106 (24) 
 
 
 
136(28) / 118 (27) 
65 (5) / 64(4) 
 
 
 
69 (4) / 69(4) 
Donges et 
al.44   
Aerobic exercise  
 
 
Control  
13 (13/0) 
 
 
8 (8/0) 
45.4 (1.7) 
 
 
49.5 (2.6) 
32.0 (1.3) 
 
 
29.6 (2.1) 
75% of age-
predicted maxHR 
during first 4 
weeks, thereafter 
80% of maxHR 
3x/week /  
40-50min 
12 CT L4 
(cm²) 
1371 (113) / 
1222 (100) 
 
1383 (164) / 
1349 (145) 
103.1 (4.6) /  
-1.9 (0.7)% 
 
92.2 (6.9) / 
+ 0.1(0.6)% 
Donges et 
al.45 
Aerobic  
 
Control  
41 (16/25) 
 
26 (13/13) 
NR 30.0 ± 5.5 
 
28.3 ± 4.1 
70-75% of max HR 3x/week / 
 30-50min 
10 DEXA 
(kg) 
1.49 ± 0.55 /  
1.38 ± 0.58 
1.44 ± 0.43 / 
1.44 ± 0.45 
84.8 ± 18.6 / 
-0.8 ± 1.9 
83.2 ± 13.4 / 
+0.6 ± 1.3kg 
Donnelly 
et al.46 
Exercise Group 
men  
Control Group 
men  
Exercise group 
women 
Control group 
women 
16 (16/0) 
 
15 (15/0) 
 
25 (25/0) 
 
18 (18/0) 
22 ± 4 
 
24 ± 4 
 
24 ± 5 
 
21 ± 4 
29.7 ± 2.9 
 
29.0 ± 3.0 
 
28.7 ± 3.2 
 
29.3 ± 2.3 
60% of HRR with a 
gradual increase to 
75% at 6 months 
5x/week /  
20-45min 
65 CT L4-L5 
(cm²) 
97.9 ± 22.5 /  
75.5 ± 18.3 
91.7 ± 29.7 / 
85.4 ± 39.7 
60.6 ± 25.5 / 
57.4 ± 28.4 
62.9 ± 21.8 / 
66.0 ± 13.9 
94.0 ± 12.6 /  
88.8 ± 9.5 
94.1 ± 11.4 / 
93.16 ± 11.6 
77.0 ± 11.4 / 
77.6 ± 12.8 
79.9 ± 8.1 /  
82.8 ±9.2 
Friedenrei
ch et al.47 
 
Aerobic exercise  
 
Control  
160 (0/160) 
160 (0/160) 
61.2±5.4 
 
60.6±5.7 
29.14.5 
 
29.3 ± 4.3 
70-80% of maxHR 3.6x/week / 
45min 
52 CT 
umbilicus 
(cm²) 
101.4 ± 55.4 /  
-16.5 
103.2 ± 56 /  
-1.6 
75.6 ± 13.0 / 
-2.3  
76.3 ± 12.7 / 
-0.5 
Gan et 
al.48 
Aerobic exercise  18 (0/18) 37.4 (1.3) 30.9 (0.7) 55-70% VO2max 4-5x/week /  
40min 
9.7 MRI  
L4-L5 (l) 
2.23 (0.12) / 2.11 
(0.12) 
94.1 (2.0) /  
92.8 (2.0) 
Giannopo
ulou et 
al.49 
 
 
Aerobic exercise 11 (0/11) 57 (entire 
study) 
35.9 (2.2) 70% HRR 3x/week /  
60-75min 
12 MRI (cm³) 5204 (598) / 
4675 (550) 
92.9 (6) / 
91.2 (5.6) 
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Reference Groups N (M/F) Age (years) BMI 
(kg/m²) 
Intensity Frequency/ 
duration per 
session  
Dura-  
tion 
(weeks) 
Assess-
ment 
VAT 
Results VAT 
(pre / post) 
Weight (kg) 
(pre/post) 
Halverstad
t et al.50 
Aerobic exercise  83 (34/49) 57.9 ± 0.6 36.0 ± 1.1 
(% body 
fat) 
50% of VO2max 
with a gradual 
increase to 70% of 
VO2max (for at 
least 14 w) 
3x/week /  
20-40min and 
addition of one 
extra low 
intensity 
exercise 
session 
 
24 CT (cm²) 127.8 (4.5) /  
-14.4 (2.4) 
80.6 ± 1.6 /  
-1.1 (0.3) 
Haus et 
al.51 
Aerobic exercise  16 (5/11) 65 ± 1 33 ± 1 60-65% max HR 
with a gradual 
increase to 80-85% 
week 4 
5x/week / 50-
60min 
12 CT (cm²) 182.4 ± 21.5 / 
134.5 ± 15.9 
95.7 ± 4.1 /  
91.9 ± 3.8 
Heydari et 
al.52 
Aerobic exercise  
 
 
 
Control  
25 (25/0) 
 
 
 
21 (21/0) 
24.7 ± 4.8 
 
 
 
25.1 ± 3.9 
28.4 ± 0.5 
 
 
 
29 ± 0.9 
80-90% of max HR 
during 8 sec sprint, 
whereafter 12 sec 
recovery 
3x/week / 
20min 
12 CT L4/L5 
(g) 
62.6 (6.2) / 
51.8 (5.1) 
 
 
69.7 (9.7) / 
67.3 (8.4) 
87.8 ± 2.7 / 
86.3 ± 2.7 
 
 
89 ± 2.9 /  
89.4 (3.1) 
Hutchison 
et al.53 
Obese 
 
 
PCOS 
8 (0/8) 
 
 
14 (0/14) 
NR 36.9 (2.1) 
 
 
75-85% of maxHR 
OR HIIT: 6-8 x 5 
minutes at 95-
100% of maxHR – 
1-2 min recovery   
3x/week / 60 
min 
(alternating 
between HIIT 
and 
continuous) 
 
12 CT L4-L5 
(cm²) 
135.1 (15.7) / 
132.7 (18.1) 
 
119.5 (16.1) / 
107.6 (15.1) 
99.4 (5.4) /  
96.9 (4.5) 
 
96.9 (4.8) /  
95.3 (4.8) 
Irving et 
al.54 
Low-intensity 
exercise  
 
High-intensity 
exercise  
 
Controls  
 
 
11 (0/11) 
 
 
9 (0/9) 
 
 
7 (0/7) 
51 ± 9 (entire 
group) 
34.7 ± 7.5 
 
34.7 ± 6.8 
 
 
 
32.7 ± 3.8 
At lactate threshold  
Midway between 
lactate threshold 
and VO2max (3 
days) ; lactate 
threshold (2 days) 
5x/week / 
duration 
depended on 
energy 
expenditure 
16 CT L4/L5 
(cm²) 
153 ± 51 / 
146 ± 49 
 
173 ± 73 / 
148 ± 59 
 
157 ± 71 / 
155 ± 71 
97.2 ± 22 /  
95.1 ± 19.3 
 
93.5 ± 18.3 / 
90.0 ± 15.6 
 
89.6 ± 11.2 / 
88.7 ± 10.6 
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Reference Groups N (M/F) Age (years) BMI 
(kg/m²) 
Intensity Frequency/ 
duration per 
session  
Dura-  
tion 
(weeks) 
Assess-
ment 
VAT 
Results VAT 
(pre / post) 
Weight (kg) 
(pre/post) 
Irwin et 
al.55 
Exercise  
 
 
Control  
87 (0/87) 
 
 
86 (0/86) 
60.7 ± 6.7 
 
 
60.6 ± 6.8 
30.4 ± 4.1 
 
 
30.5 ±3.7 
Start 40% of 
maxHR with a 
gradual increase to 
60-75% by week8 
5x/week / 
45min 
52 CT L4-L5 
(g/cm²) 
147.6 (134.3-161) 
/ -8.5 
 
147.6 (135.4-
159.8) / +0.1 
81.4 ± 14.1 / 
-1.3% 
 
81.7 ± 12.1 / 
0.1% 
Janssen 
et al.56 
 
 
Aerobic exercise 
in black men  
Aerobic exercise 
in white men  
 
Aerobic exercise 
in black women   
Aerobic exercise 
in white women 
84 (84/0) 
 
255 (255/0) 
 
 
160 (0/160) 
 
243 (0/243) 
Not depicted 
for entire 
groups 
27.0 ± 4.8  
 
26.7 ± 4.9 
 
 
28.2 ± 6.1 
 
24.9 ± 4.8 
75% of VO2max  3x/week / 50 
min 
20 CT L4-L5 
(cm²) 
77.5 ± 5.1 / 
71.9 ± 52.2 
109.5 ± 63.6 / 
102.4 ± 61.2 
 
69.1 ± 40.8 /  
65.4 ± 37.9 
75.4 ± 52.7 /  
72.2 ± 49.1 
83.9 ± 16.3 /  
- 0.5 ± 2.4 
84.3 ± 16.3 / 
-0.3 ± 2.1 
 
73.8 ± 16.3 / 
-0.4 ± 3.0 
67.0 ± 13.6 /  
-0.1 ± 2.1 
Johnson 
et al.57 
Aerobic exercise  
 
Stretching 
control  
12 (N.R.) 
 
7 (N.R.) 
49.1 (2.3) 
 
47.3 (3.6) 
32.2 (0.8) 
 
31.1 (1.1) 
Week 1: 50% of 
VO2p Week 2: 60% 
VO2p  
Week 3 and 4: 70% 
VO2p 
3x/week /  
30-45 min 
(interval:15 
min training, 5 
min rest) 
4 MRI L4-
L5 (cm²) 
 
154.3 (18.3) /  
143.6 (18.7) 
154.3 (21.2) / 
158.6 (23.9) 
94.4 (3.8) /  
94.1 (4.0) 
98.8 (6.0) /  
98.6 (6.3) 
Jung et 
al.58 
Moderate 
intensity  
Vigorous 
intensity  
Control  
8 (0/8) 
 
8 (0/8) 
 
12 (0/12) 
56.8 ± 8.2 
 
48.4 ± 6.1 
 
55.5 ± 7.6 
25.5 ± 1.5 
 
25.9 ± 1.6 
 
27.7 ± 3.4 
Goal: intensity at 
3.5- 5.2 METs 
Goal: intensity at > 
5.3 METs 
 
5x/week / 
60min 
(moderate 
intensity) vs. 
30min 
(vigourous 
intensity) 
12 CT L4-L5 
(cm²) 
15784.6±4662.7 / 
13262.5 ± 3217.8 
13726.6±3011.8 / 
12447.4 ± 2252.6 
17790.2±5621.7 / 
17372.7 ± 5235.7 
63.7 ± 5.0 / 
-2.9% ± 2.5% 
62.9 ± 4.4 / 
-2.5% ± 2.3% 
67.3 ± 9.8 / 
-1.5% ± 1.6% 
Karstoft et 
al.59 
Continuous 
walking group  
 
Interval walking 
group  
 
Control group  
12 (8/4) 
 
 
12 (7/5) 
 
 
8 (5/3) 
60.8 ± 2.2 
 
 
57.5 ± 2.4 
 
 
57.1 ± 3.0 
29.9 ± 1.6 
 
 
29.0 ± 1.3 
 
 
29.7 ± 1.9 
>55% of peak 
energy expenditure  
Walking at 70% of 
peak energy 
expenditure for 3 
minutes, alternated 
with 3 minutes of 
slow walking 
5x/week / 
60min 
17 MRI, 
below 
diaphrag
m (l) 
 
 
4.5 ± 0.3 / 
4.2 ± 0.4 
 
4.7 ± 0.8 / 
4.2 ± 0.7 
 
4.7 ± 0.4 / 
4.6 ± 0.4 
88.2 ± 4.7 /  
87.5 ± 4.8 
 
84.9 ± 4.9 / 
80.7 ± 4.1 
 
88.5 ± 4.7 / 
89.2 ± 5.2 
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Reference Groups N (M/F) Age (years) BMI 
(kg/m²) 
Intensity Frequency/ 
duration per 
session  
Dura-  
tion 
(weeks) 
Assess-
ment 
VAT 
Results VAT 
(pre / post) 
Weight (kg) 
(pre/post) 
Kim et 
al.60 
Aerobic exercise  24 (24/0) 49.4 ± 9.6 30.7 ± 3.3 Gradual increase of 
50-60% of maxHR 
to 60-70%  
3x/week / 
60min 
12 CT L4-L5 
(cm²) 
197.1 ± 61.9 / 
165.7 ± 57.0 
87.7 ± 11.2 / 
 -4.2% 
Ku et al.61  Aerobic exercise  
 
 
Control  
15 (0/15) 
 
 
16 (0/16) 
55.7 ± 7.0 
 
 
57.8 ± 8.1 
27.1 ± 2.4 
 
 
27.4 ± 2.8 
40-50% of maximal 
exercise capacity 
5x/week / 
60min 
12 CT (g) 15890 ± 4593 / 
15038 ± 3369 
 
17530 ± 4747 / 
17362 ± 4728 
66.3 ± 6.0 / 
-1.9 ± 1.2 
 
67.6 ± 7.5 / 
-0.6 ± 0.7 
Kwon et 
al.62 
Aerobic exercise  
 
Control  
13 (0/13) 
 
14 (0/14) 
55.5 ± 7.5 
 
57.5 ± 8.6 
27.0 ± 2.5 
 
27.5 ± 3.0 
Anaerobic 
threshold  
5x/week / 
60min 
12 CT L4-L5 16291.5±4808/ 
14682.7±3494 
17204.5±4674/ 
17216.3±4560 
66.3 ± 6.5 / 
NR 
68.0 ± 7.9 / 
NR 
Lee et al.63 Obese  
 
 
T2D  
8 (8/0) 
 
 
9 (9/0) 
47.1 ± 8.1 
 
 
51.0 ± 8.0 
32.4 ± 1.6 
 
 
29.9 ± 3.2 
~60% of VO2peak 5x/week / 
60min 
13 MRI 5cm 
below to 
15 cm 
above L4-
L5 (kg) 
9.2 ± 1.2 / 
8.3 ± 1.1 
 
7.5 ± 1.3 /  
6.7 ± 1.5 
97.6 ± 8.9 /  
97.2 ± 8.9 
 
93.5 ± 7.6 / 
93.9 ± 8.5 
Liao et 
al.64 
Aerobic exercise  
 
Stretching 
control group  
32 (9/23) 
 
32 (17/15) 
55.8 (1.8) 
 
52.2 (1.8) 
25.6 (0.8) 
 
26.6 (0.8 
50% of HRR, with a 
gradual increase to 
70%  
3x/week / 
60min 
26 CT (cm²) 86.3 (8.1) /  
-16.1 
112.3 (9.9) /  
-14.5 
66.1 (2.9) / 
-2.7 (0.4) 
69.7 (2.6) /  
-0.9 (0.3) 
Malin et 
al.65 
Aerobic exercise  35 (16/19) 66.8 ± 0.8 35.1 ± 0.7 60-65% of maxHR 
first four weeks, 
thereafter increase 
to 80-85% 
5x/week /  
50-60min 
12 CT (cm³) 151.4 (14) /  
-30.6 
99.0 ± 2.4 / 
- 8.1 ± 0.7 
Malin et 
al.66 
Impaired fasting 
glucose  
Impaired 
glucose 
tolerance 
Combined 
glucose 
intolerance  
Normal glucose 
12 (8/4) 
 
9 (4/5) 
 
 
22 (7/15) 
 
 
15 (4/11) 
65.1 ± 0.6 
(entire group) 
33.8 ± 1.0 
 
32.7 ± 1.1 
 
 
35.6 ± 1.0 
 
 
32.3 ± 1.2 
60-65% of maxHR 
first four weeks, 
thereafter increase 
to 80-85%  
5x/week / 
50-60min 
12 CT (cm²) 139.9 ± 16.8 / 
86.6 ± 14.4 
215.9 ± 76.6 / 
140.9 ± 45.2 
 
187.7 ± 19.1 / 
172.2 ± 19.9 
 
137.4 ± 23.9 / 
100 / 89.9 
 
94.5 / 87.3 
 
 
96.9  / 90.1 
 
 
90.1 / 84.5 
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tolerant 
Type 2 diabetes  
 
18 (7/11) 
 
34.1 ± 1.3 
90.5 ± 21.2 
139.9 ± 23.7 /  
109.0 ± 18.1 
 
94 / 90.4 
Reference Groups N (M/F) Age (years) BMI 
(kg/m²) 
Intensity Frequency/ 
duration per 
session  
Dura-  
tion 
(weeks) 
Assess-
ment 
VAT 
Results VAT 
(pre / post) 
Weight (kg) 
(pre/post) 
McKenzie 
et al.67 
Males, GG 
genotype  
Males, GT + TT 
genotype  
Females, GG 
genotype  
Females, GT + 
TT genotype  
29 (29/0) 
 
21 (21/0) 
 
38 (0/38) 
 
20 (0/20) 
58 ± 1 
 
61 ± 1 
 
57 ± 1 
 
58 ± 1 
28.7 ± 0.7 
 
27.3 ± 0.8 
 
27.7 ± 0.7 
 
27.9 ± 1.0 
50-70% of HRR  
 
3-4x/week /  
20-40min 
24 CT (cm²) 150 (129-175) /  -
20.1 (5.6) 
131 (110-156) / -
29.9 (9.2) 
110 (100-121) / -
7.9 (3.1) 
111 (97-127) / 
-0.2 (5.6) 
91.1 ± 2.7 / 
-1.3 
86.7 ± 3.1 / 
-2.3 
73.8 ± 2.0 / 
-0.4 
76.0 ± 2.8 / 
-1.1 
McTiernan 
et al.68 
Women, aerobic 
exercise  
Women, 
controls  
Men, exercisers  
 
Men, controls  
49 (0/49) 
 
51 (0/51) 
 
51 (51/0) 
 
51 (51/0) 
54.4 ± 7.1 
 
53.7 ± 5.6 
 
56.2 ± 6.7 
 
56.6 ± 7.6 
28.9 ± 5.5 
 
28.5 ± 4.5 
 
29.7 ± 3.7 
 
30.1 ± 4.8 
60-85% of maxHR 6x/week / 
60min 
52 CT L4-L5 
(cm²) 
105.9 ± 60.8 /  
100.1 ± 58.8 
102.6 ± 55.8 / 
104.2 ± 59.6 
161.8 ± 66.3 / 
149.6 ± 76.6 
176.7 ± 79.1 / 
170.5 ± 73.3 
78 ± 17.8 / 
-1.4 ± -1.8% 
77.9 ± 12.8 / 
+0.7 ± 0.9% 
94.8 ± 14.9 / 
-1.8 ± -1.9% 
97.4 ± 18.2 / 
+0.7 ± 0.9% 
Miyatake 
et al.69 
Aerobic exercise  25 (25/0) NR 28.5 ± 2.3 60% of maximum 
HR and walking of 
an extra 1000 
steps/day  
1x/week 
supervised 
and daily 
walking / 
duration NR 
 
52 CT (cm²) 109.8 ± 57.2 / 
 82.7 ± 42.6 
81.3 ± 7.9 / 
78.1 ± 7.4 
Moghades
i et al.70 
Aerobic exercise  
 
Control  
8 (8/0) 
 
8 (8/0) 
NR 30.3 ± 2.1 
 
32.0 ± 5.3 
Walking 2 miles on 
40-59% VO2max 
4x/week / 
30min 
12 MRI L4-
L5 (cm³) 
651.1 ± 31.8 / 
602.2 ± 13.7 
688.4±106.2/ 
692.2 ± 108.8 
86.1 ± 4.6 / 
84.1 ± 4.3 
90.4 ± 13.9 /  
90.6 ± 14.1 
O’Leary et 
al.71 
Aerobic exercise  16 (5/11) 63 (1) 33.2 (1.4) Start at 60-65% of 
maxHR with a 
gradual increase to 
80-85%  
 
5x/week /  
50-60min 
12 CT L4-
L5(cm²) 
175.6 (20.2) / 
136.2 (16.9) 
94.1 (4.3) / 
90.9 ( 4.0) 
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Reference Groups N (M/F) Age (years) BMI 
(kg/m²) 
Intensity Frequency/ 
duration per 
session  
Dura-  
tion 
(weeks) 
Assess-
ment 
VAT 
Results VAT 
(pre / post) 
Weight (kg) 
(pre/post) 
Park et 
al.72 
Aerobic exercise  
 
Control  
10 (0/10) 
 
10 (0/10) 
42.2 ± 1.91 
 
43.1 ± 1.67 
25.3 ± 1.74 
 
25.5 ± 0.86 
60-70% of maxHR 
 
 
6x/week / 
60min 
24 
 
CT 
umbilicus 
195.0 ± 12.55 / 
112.4±10.50 
182.9 ± 16.81 / 
190.4±15.74 
63.7 ± 2.58 / 
- 4.7 kg 
65.2 ± 1.87 / 
+0.6kg 
Prior et 
al.73 
Aerobic exercise  
 
34 (34/0) 
 
62 ± 1 28.9 ± 0.7 50-70% of VO2max  3x/week /  
20-45min 
26 CT L4-L5 
(cm²) 
154 (13) / 138.3 91.4 ± 2.4 / 
-1.6% 
Pritchard 
et al.74 
Aerobic exercise  14 (14/0) 21.0 ± 0.8 26.2 ± 5.5 50-55% of VO2max 7x/week / 
57min 
13 CT L4-L5 
(cm²) 
80.8 ± 19.0 / 52.1 
± 22.4 
82.1 ± 19.9 / 
77.1 ± 19.0 
Redman et 
al.75 
Aerobic exercise  8 (0/8) 25 ± 1 32.0 ± 1.6  55% of VO2max 5x/week / 
23min week 1-
4; gradual 
increase to 
58min week 
12-16 
16 MRI (kg) 1.3(0.9-1.9) / 
1.2 (0.7-1.7) 
84.6 ± 5.8 
-1 ± 2% 
Reichkend
ler et al.76 
Moderate dose 
aerobic exercise  
High dose 
aerobic exercise  
Control  
18 (18/0) 
 
18 (18/0) 
 
17 (17/0) 
30 ± 2 
 
28 ± 1 
 
31 ± 1 
28.6 ± 0.4 
 
27.6 ± 0.3 
 
28.0 ± 0.6 
VO2max > 70%  
VO2max 50-70%  
3x/week / 
duration 
depended on 
EE 
4x/week / 
duration 
depended on 
EE 
11 MRI L4-
L5 (kg) 
2.2 ± 0.8 kg /  
1.9 ± 0.6 kg 
2.0 ± 0.7 kg /  
1.6 ± 0.4 kg 
2.0 ± 0.6kg /  
2.1 ± 0.6 kg 
93.2 ± 1.9 / 
89.6 ± 2.0 
91.3 ± 1.7 /   
88.8 ± 1.6 
92.8 ± 2.1 / 
92.9 ± 2.1 
Sasai et 
al.77 
Moderate intra-
abdominal fat  
High intra-
abdominal fat  
33 (33/0) 
 
24 (24/0) 
52.9 ± 10.6 
 
53.5 ± 9.5 
29.2 ± 3.1 
 
30.3 ± 3.1 
Anaerobic treshold 3x/week / 
90min 
12 CT (cm²) 149.7 ± 35.4 / 
134.6 ± 43.1 
242.4 ± 34.4 / 
199.1 ± 39.7 
80.9 ± 10.1 / 
-2.3 ± 2.2 
88.8 ± 11.3 / 
-3.2 ± 3.0 
Sasai et 
al.78 
Low volume 
exercise 
 
High volume 
exercise  
19 (19/0) 
 
 
18 (18/0) 
49.7 ± 8.2 
 
 
45.4 ± 8.6 
31.0 ± 4.1 
 
 
29.3 ± 2.0 
65-80% of maxHR 3x/week /  
30-60min 
12 CT (cm²) 188.1 ± 53.9 / 
170.3 ± 46.6 
 
167.9 ± 44.3 / 
137.9 ± 40.6 
89.8 ± 13.4 / 
-2.7 ± 3.1 
 
85.7 ± 9.6 / 
-3.4 ± 2.6 
Schwartz 
et al.79 
Young men  
 
Older men  
13 (13/0) 
 
15 (15/0) 
28.2 ± 2.4 
 
67.5 ± 5.8 
26.0 ± 3.5 
 
26.2 ± 2.7 
50-60% of HRR 
with a gradual 
increase to 85% 
5x/week / 
45min 
27 CT (cm²) 66.3 ± 37.1 /  
54.8 ± 33.6 
144.5 ± 49.4 / 
85.1 ± 15.0 / 
84.6 ± 13.4 
79.6 ± 7.9 / 
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109.0 ± 44.9 77.1 ± 7.8 
Reference Groups N (M/F) Age (years) BMI 
(kg/m²) 
Intensity Frequency/ 
duration per 
session  
Dura-  
tion 
(weeks) 
Assess-
ment 
VAT 
Results VAT 
(pre / post) 
Weight (kg) 
(pre/post) 
Shojaee-
Moradie et 
al.80 
Aerobic exercise  
 
Control 
10 (10/0) 
 
7 (7/0) 
47 ± 3 
 
55 ± 4 
27.6 ± 0.6 
 
27.6 ± 0.9 
60-85% of VO2max 3x/week / 
>20min 
6 CT L4-L5 
(cm²) 
169.8 ± 13.1 / 
139.2 ± 10.0 
197.0 ± 25.6 / 
181.4 ± 26.7 
87.4 ± 2.8 /  
87.6 ±2.6 
84.1 ± 2.5 / 
83.3 ± 2.4 
Sigal et 
al.81 
Aerobic training 
group  
Control  
60 (39/21) 
 
63 (41/22) 
53.9 ± 6.6 
 
54.8 ± 7.2 
35.6 ± 10.1 
 
35.0 ± 9.5 
60-75% of max HR  3x/week /15-
45min 
22 CT L4-L5 
(cm²) 
257 ± 161 / 
244 ± 161 
252 ± 147 / 
250 ± 147 
 
103.5 ± 31.0 
/100.9 ± 30.2 
101.3 ± 28.6 
/101.0 ± 27.8 
Slentz et 
al.82 
 
 
Low Amount, 
moderate 
intensity  
 
 
Low Amount, 
vigorous 
intensity  
 
 
High amount, 
vigorous 
intensity  
Control  
40 (22/18) 
 
 
 
 
46 (23/23) 
 
 
 
 
42 (23/19) 
 
 
47 (23/24) 
54.0 ± 5.5 
 
 
 
 
53.0 ± 7.0 
 
 
 
 
51.5 ± 5.3 
 
 
52.3 ± 7.7 
29.8 ± 3.2 
 
 
 
 
29.7 ± 3.1 
 
 
 
 
29.1 ± 2.4 
 
 
29.8 ± 3.0 
40-55% of VO2max 
in order to reach 
walking 
19.2km/week 
65-80% of VO2max 
in order to reach 
jogging 
19.2km/week 
65-80% of VO2max 
in order to reach 
levels of jogging 
32.0km per week 
Duration and 
frequency 
depended on 
set goal for 
distance/intens
ity 
34-39 CT at L4 
pedicle  
173 ± 72 / 
 +1.7 ± 19.7% 
 
 
 
154 ± 55 /  
+2.5 ± 21.3% 
 
 
 
168 ± 64 / 
 -6.9 ± 20.8% 
 
165 ± 68 /  
+8.6 ± 17.2% 
88.0 ± 16.3 / 
-0.7% 
 
 
 
85.0 ± 13.4 / 
-0.8% 
 
 
 
85.7 ± 12.2 / 
-2.6% 
 
 86.9 ± 14.2 /  
-1.0% 
Solomon 
et al.83 
Aerobic exercise 
and low 
glycemic index 
isocaloric diet 
Aerobic exercise 
and high 
glycemic index 
isocaloric diet  
 
10 (2/7) 
 
 
 
12 (5/7) 
67 (2) 
 
 
 
64 (1) 
34.9 (1.1) 
 
 
 
34.1 (1.1) 
~85% of maximum 
heart rate 
5x/week / 
60min 
12 CT (cm²) 106.9 (12.7) / 
78.7 (12.1) 
 
 
117.5 (26.3) /  
73.0 (18.5) 
 
97.4 (3.8) /  
89.6 (3.4) 
 
 
94.7 (4.4) /  
85.7 (4.1) 
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Reference Groups N (M/F) Age (years) BMI 
(kg/m²) 
Intensity Frequency/ 
duration per 
session  
Dura-  
tion 
(weeks) 
Assess-
ment 
VAT 
Results VAT 
(pre / post) 
Weight (kg) 
(pre/post) 
Yassine et 
al.84 
Aerobic exercise  
 
12 (NR) 64 ± 2 35.3 ± 5.8 Initially 60-65 of 
maxHR with a 
gradual increase to 
80-85%  
5x/week /  
50-60min 
12 CT (cm²) 192.3 ± 104.3 
/ 158.4 ± 87.0 
 
99.7 ± 15.7 / 
95.9 ± 14.6 
Yoshimur
a et al.85 
High liver fat 
group 
 
Low liver fat 
group 
13 (5/8) 
 
14 (6/8) 
NR 30.2 ± 5.7 
 
25.5 ± 3.2 
Lactate treshold 3/week / 
60min 
12 CT L4-L5 
(cm²) 
213 ± 63 /  
187 ± 66 
139 ± 59 /  
116 ± 61 
78.3 ± 17.1 / 
-3.6% 
66.0 ± 11.8 / 
-3.3% 
 
Hypocaloric diet studies 
Reference Groups N (M/F) Age (years) BMI (kg/m²) Caloric restriction Duration 
(weeks) 
Assessment 
VAT 
Results VAT 
(pre / post) 
Weight (kg) 
(pre/post) 
Alvarez et 
al.86 
Obese, old  
Obese, young  
6 (6/0) 
 
6 (10/0) 
 60 (2.7) 
 
32.9 (2.3)                                        
28.9 (1.1) 
 
30.4 (1.0) 
Reduction of 500-800 
kcal/day  
13 CT (cm²) 184 (27) /  
140 (31) 
135 (17) /  
107 (14) 
91.2 (4.1) / 
83.9 (4.0) 
 97.9 (4.3) / 
90.2 (3.8) 
Banasik et 
al.87 
VLCD  15 (2/13) 39.6 ± 13.4 36.2 ± 6.3 
 
Restriction to 800 kcal/day 4 CT L4-L5 
(cm²) 
139.8 ± 82 / 
120.8±85.9 
104.1 ± 26.8 
/ 
97.3 ± 26.4 
Bosy-
Westphal 
et al.88 
LCD  30 (0/30) 31.4 ± 6.0 35.5 ± 4.9 Restriction to 800-1000 
kcal/day 
14.2 MRI (cm³) 1757 ± 826 / 
1530 ± 755 
 
101.0 ± 18.3/ 
91.2 ± 17.4 
Brochu et 
al.89 
 
LCD  71 (0/71) 58.0 ±  4.7 
 
 
32.2 ± 4.6 
 
 
Reduction of 500-800 kcal of 
baseline resting metabolic 
rate (determined by indirect 
calorimetry) 
26 CT L4-L5 
(cm²) 
186 ± 56 / 
-23 ± 30 
83.6 ± 14.4 / 
- 5,1 ± 4,7 
Chan et 
al.90 
Hypocaloric diet  
 
Isocaloric diet  
20 (20/0) 
 
15 (15/0) 
46 ± 8 (entire 
group) 
35 ± 1.0 
 
31 ± 0.7 
reduction in energy intake by 
~33% 
16 MRI (kg) 7.1 ( 0.5) / 
5.4 (0.4) 
6.9 (0.4) / 
6.7 (0.4) 
109 (2) / 
96 (3) 
105 (3) / 
109 (2) 
Colles et 
al.91 
 
VLCD  32 (19/13) 47.5 ± 8.3 47.3 ± 5.5 Restriction to 456-680 
kcal/day 
12 CT and MRI 
L2-L3 (cm²) 
346.3 ± 103.3 / 
285.1 ± 89.3 
139.8 ± 11.0/ 
 125.0 ± 11.7 
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Reference Groups N (M/F) Age (years) BMI (kg/m²) Caloric restriction Duration 
(weeks) 
Assessment 
VAT 
Results VAT 
(pre / post) 
Weight (kg) 
(pre/post) 
Collins et 
al.92 
LCD  30 (3/27) 53  56.0 (1.0) Restriction to 800kcal/day 9 CT (cm²) 388.0 (31.2) / 
342.1 (23) 
NR 
Conway et 
al.93 
VLCD and LCD in 
black women  
 
VLCD and LCD in 
white women  
8 (0/8) 
 
 
10 (0/10) 
34.8 ± 7.2 
 
 
38.6 ± 6.3 
40.0 ± 5.0 
 
 
38.2 ± 8.1 
During first twelve weeks: 
restriction to 800 kcal/day 
During week 12-24: 
restriction to 1200-1500 
kcal/day 
24 CT L4-
L5(cm²) 
 
105 (25) / 
74 (23) 
 
160 (70) / 
105 (63) 
NR 
Cooper et 
al.94 
LCD  
 
(2/43) 47.5 ± 6.2 
 
 
44.0 ± 6.6 
 
 
Restriction to 1200-2100 
kcal/day 
52 CT (cm²) 186.9 ± 62.9 / 
-28.7 ± 46. 
118.6 ± 16.6/ 
-8.8 ± 5.9 
Dengo et 
al.95 
LCD  
 
Control  
36 (15/11) 
(combined 
groups) 
61.2 (0.8) 
 
66.1 (1.9) 
30.0 (0.6) 
 
31.8 (1.4) 
Restriction to 1200-1500 
kcal/day 
12 CT (cm²) 177 (15) / 
133 (12) 
188 (18) /  
186 (17) 
84.6 (2.6) / 
77.5 (2.2) 
91.0 (4.8) / 
90.4 (4.9) 
Trussardi 
Fayh et 
al.96 
LCD only  
 
18 (6/12) 30.1 ± 5.5 
 
 
34.7 ± 2.4 
 
 
Reduction of 500-1000 
kcal/day 
11.4 CT L4-L5 
(cm²) 
136.1 ± 64.0 / 
112.5 ± 54.0 
 
95.8 ± 13.7 / 
91.5 ± 14.2 
 
Fisher et 
al.97 
LCD  29 (0/29) NR 28 ± 1 Restriction to 800 kcal/day 8 CT L4-L5 
(cm²) 
93 ± 35 / 
58 ± 26 
78 ± 8 / 
66 ± 7 
Fujioka et 
al.98 
LCD in visceral fat 
obesity  
LCD in 
subcutaneous fat 
obesity  
14 (0/14) 
 
26 (0/26) 
39.6 ± 9.4 
 
37.1 ± 9.9 
34.3 ± 3.2 
 
36.0 ± 5.7 
Gradual decrease over 8 
weeks to 800 kcal/day 
restriction, and rise to ~1100 
kcal/day before discharge 
8 CT (l) 6.9 ± 3.1 / 
4.3 ± 2.9 
3.9 ± 1.7 /  
2.6 ± 1.1 
83.9 ± 12.8 / 
71.9 ± 10.4 
87.6 ± 17.3 / 
75.3 ± 15.1 
Gasteyger 
et al.99 
LCD in women  
 
LCD in men  
85 (0/85) 
 
26 (26/0) 
Median  
43 (21-67) 
41 (20-61) 
Median 
37.3 (31.4 -
48.8) 
36.6 (33.5 – 
41.9) 
Restriction to 800-1000 
kcal/day 
8 MRI L4-L5 
(cm²) 
123 (44-288) / 
-23.7% 
162 (73-265) / 
-38.4% 
Only %loss: 
-6 ± 5% 
0 ± 2% 
 
Giannopo
ulou et 
al.49 
 
LCD  11 (0/11) 57 (no SE) 35.9 (2.2) Reduction of 600 kcal/day 14 MRI (cm³) 4785 (480) / 
4425 (435) 
 
92.4 (5.9) / 
88.8 (5.7) 
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Reference Groups N (M/F) Age (years) BMI (kg/m²) Caloric restriction Duration 
(weeks) 
Assessment 
VAT 
Results VAT 
(pre / post) 
Weight (kg) 
(pre/post) 
Goss et 
al.100 
High glycemic load 
LCD  
 
Low glycemic load 
LCD  
29 (14/15) 
 
 
40 (17/23) 
34.6 ± 8.1 
 
 
35.6 ± 4.3 
30.9 ± 4.5 
 
 
32.4 ± 4.1 
8 weeks eucaloric diet 
8 weeks hypocaloric diet with 
a 1000 kcal-deficit 
8 CT L4-L5 
(cm²) 
80.6 ± 48.3 / 
82.4 ± 57.9 
 
89.5 ± 46.3 / 
81.5 ± 49.4 
94.3 ± 20.4 / 
89.4 ± 20.9 
 
98.4 ± 17.9 / 
92.9 ± 18.1 
Gray et 
al.101 
VLCD  10 (0/10) 37 ± 4 35.1 ± 2.1 Restriction to 650 kcal/day 10 MRI (cm²) 96 ± 36 / 
70 ± 26 
90.6 ± 8.1 / 
-10.6 ± 3.8 
Gu et al.102 VLCD  46 (27/19) NR 32.6 ± 0.6 Restriction to < 800 kcal/diet 8 MRI L4-L5 
(cm²) 
113.9 (5.8) / 
79.8 (3.7) 
96.1 (2.7) / 
87.4 (2.5 
Haufe et 
al.103 
Reduced 
carbohydrate LCD  
 
 
Reduced fat LCD  
52 (8/44) 
 
 
 
50 (10/40) 
Subgroups: 
42 ± 9 and  
45 ± 8 
 
44 ± 9 and 
46 ± 9 
Subgroups: 
32.0 ± 3.3 
and 35.6±4.7 
 
31.9 ± 3.9 
and 33.9 ± 3 
Reduction of ~30% baseline 
food (to a minimum of 1200 
kcal) 
26 MRI (kg) 
 
 
1.8 ± 1.1 / 
1.4 ± 0.9 
 
 
1.9 ± 1 / 
1.5 ± 0.9 
95.0 ± 15.9 / 
89.5 ± 14.9 
 
 
93.6 ± 17.3 / 
89.4 ± 17.0 
Ibanez et 
al.104 
LCD  
 
Control  
12 (0/12) 
 
9 (0/9) 
51.4 ± 5.5 
 
50.2 ± 6.8 
34.6 ± 3.4 
 
35.0  ± 3.6 
Reduction of 500 kcal/day 
 
 
16 MRI (cc) 3340 ± 977 / 
2724 ± 1052 
3175 ± 1122 / 
3157 ± 1073 
 88.0 ± 15.2 / 
 82.3 ± 14.0 
88.9 ± 11.4 / 
88.8 ± 10.5 
Jang et 
al.105 
LCD  177 (NR) 40.0 (1.04) 27.1 (0.22) Reduction of 300 kcal/day 12 CT L4 (cm²) 88.3 (2.81) / 
77.8 (2.58) 
71.1 (0.69) / 
67.8 (0.58) 
Janssen 
et al.106 
Men, LCD  
 
Women, LCD  
10 (10/0) 
 
10 (0/10) 
45.6 (2.1) 
 
39.6 (2.4) 
31.6 (0.9) 
 
34.5 (1.4) 
Reduction of 1000 kcal/day 
from baseline isocaloric diet 
16 MRI 5 cm 
below L4-L5 
to 15cm 
above L4-L5 
(cm²) 
188  (22) / 
-58 (10) 
142 (17) / 
-51 (7) 
 
98.1 (3.5) / 
-12% 
92.9 ( 5.0) / 
-12% 
 
Kanai et 
al.107 
LCD  26 (0/26) 50 ± 13 33.7 ± 3.1 Restriction to 1200 kcal/day 12 CT umbilicus 
(cm²) 
168 ± 12 / 
124 ± 65 
81.3 ± 12.1 / 
71.9 ± 10.0 
Kim et 
al.108 
LCD in wild type 
 
LCD in only UCP3 
variant  
224 
(144/110) 
(entire 
study) 
52.7 (1.31) 
 
52.4 (1.05) 
 
25.9 (0.29) 
 
25.8 (0.29) 
 
Reduction of 300 kcal/day 12 CT L1 (cm²) 274.1 (10.4) / 
254.0 (10.6) 
296.8 (10.5) / 
276.7 (9.6) 
69.3 (1.17) / 
65.9 (1.17) 
69.4 (1.06) / 
66.1 (1.04) 
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LCD in only β3-AR 
variant  
LCD in both variants  
55.4 (1.52) 
 
54.3 (1.65) 
25.9 (0.64) 
 
25.4 (0.51) 
281.9 (10.5) / 
273.2 (9.6) 
281.0 (10.5) / 
272.3 (10.5) 
67.4 (1.69) / 
63.9 (1.68) 
70.0 (2.13) / 
66.7 (2.09) 
Reference Groups N (M/F) Age (years) BMI (kg/m²) Caloric restriction Duration 
(weeks) 
Assessment 
VAT 
Results VAT 
(pre / post) 
Weight (kg) 
(pre/post) 
Kim et 
al.109  
LCD  27 (27/0) 45.8 (1.7) 30.5 (0.7) Average restriction to 1547 
kcal/day  
12 CT umbilicus 
(cm²) 
195.1 (14.2) / 
129.4 (10.9) 
89.4 (2.4) / 
79.9 (2.7) 
Kockx et 
al.110 
LCD  50 (25/25) 38.4 ± 5.5 31.3 ± 4.5 Reduction of 1000 kcal/day 13 MRI (cm²) 98 ± 31 / 
66 ± 26 
85.9 ± 8.8 / 
74.9 ± 8.9 
Laaksone
n et al.111 
VLCD  20 (9/11) 46.7 ± 8.7 35.8 ± 9.5 Restriction to 800 kcal/day 9 CT L4 (cm²) 216 ± 49 / 
148 ± 31 
101.3 ± 12.0 
/ 
86.4 ± 9.6 
Langendo
nk et al.112 
VLCD in lower body 
obese 
VLCD in upper body 
obese  
8 (0/8) 
 
 
8 (0/8) 
35.0 (1.7) 
 
38.3 (2.9) 
33.2 (1.6) 
 
33.9 (1.1) 
Restriction to 478 kcal/day 17 MRI L4-L5 
(cm²) 
303 (37) / 
155 (25) 
583 (77) / 
359 (47) 
 93.4 (5.0) / 
79.2 (4.7) 
 94.1 (3.0) / 
79.7 (2.3) 
Larson-
Meyer et 
al.113 
Control  
 
LCD  
11 (5/6) 
 
12 (6/6) 
37 (7) 
 
39 (5) 
27. 8 (2.0) 
 
27.8 (1.4) 
Reduction of -25% from 
baseline energy 
requirements 
24 CT L4-L5 
(kg) 
2.9 (0.4) / 
2.8 (0.4) 
3.2 (0.5) / 
2.3 (0.4) 
 81.8 (2.8) / 
81.9 (2.8) 
81.0 (3.3) / 
72.6 (3.1) 
Lee et 
al.114 
LCD  33 (0/33) 32.4 ± 8.5 27.1 ± 2.3 Restriction to 1200 kcal/day 12 CT L4-L5 
(cm²) 
79.6 ± 28.3 / 
76.9 ± 29.1 
70.2 ± 8.2 /  
68.2 ± 6.4 
Leenen et 
al.115 
LCD in women  
 
LCD in men  
33 (0/33) 
 
27 (27/0) 
39 ± 5 
 
40 ± 6 
31.3 ± 2.2 
 
30.7 ± 2.2 
Reduction of 1000 kcal/day 13 MRI (cm²) 103 ± 35 / 
-33 ± 21 
155 ± 38/ 
-61 ± 26 
86.9 ± 7.6 / 
-12.4 ± 4.3 
97.4 ± 8.0 / 
-13.5 ± 3.5 
Maki et 
al.116 
LCD with 
diacylglycerol 
supplements  
LCD with 
triacylglycerol 
supplements  
65 (25/40) 
 
 
62 (25/38) 
49.9 ± 11.4 
 
 
48.1 ± 11.2 
34.5 ± 3.7 
 
 
33.9 ± 3.7 
Individual diet with reduction 
of 500-800 kcal/day 
24 CT L4-L5 
(cm²) 
150.4 ± 10.7 / 
-38 ± 3 
 
160.6 ± 9.9 / 
-17 ± 8 
 
NR 
Murakami 
et al.117 
LCD  
 
18 (10/8) 48.2 (1.9) 27.8 (0.5) 
 
 
Restriction to 1000-1500 
kcal/day (women); 1500-
1700 kcal/day (men) 
12 CT (cm² 130.6 (16.1) / 
97.9 (11.4) 
 
72.5 (2.2) / 
66.4 
71.5 (2.0) / 
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 62.9 (1.8) 
Reference Groups N (M/F) Age (years) BMI (kg/m²) Caloric restriction Duration 
(weeks) 
Assessment 
VAT 
Results VAT 
(pre / post) 
Weight (kg) 
(pre/post) 
Ng et al.118 LCD  20 (20/0) NR 35.2 (1.0) Restriction to 1467 kcal/day 14 MRI (kg) 7.1 (0.5) / 
5.4 (0.4) 
109.3 (2.3) / 
96.0 (2.7) 
Nicklas et 
al.119 
LCD  34 (0/100) 58.4 ± 6.0 33.9 ± 4.0 Reduction of 400 kcal/day  20 CT L4-L5 
(cm³) 
2369 ± 870 / 
-612 ± 338 
91.8 ± 10.4 / 
-11.8 ± 4.1 
Okhawara 
et al.120 
LCD  9 (9/0) 50.1 ± 12.9 27.9 ± 2.3 Restriction to 1680 kcal/day 
 
13 CT umbilicus 
(cm²) 
186 ± 41.9 / 
97 ± 17.7 
81.1 ± 5.6 / 
69.4 ± 4.4 
Okura et 
al.121 
LCD in intra-
abdominal fat obesity  
LCD in 
subcutaneous fat 
obesity  
31 (0/31) 
 
34 (0/34) 
NR 29.4 ± 3.2 
 
27.8 ± 2.0 
Restriction to 1130 kcal/day  14 CT L4-L5 
(cm²) 
148 ± 41 / 
-37 ± 19 
68 ± 24 / 
-23 ± 17 
71.5 ± 8.8 / 
-7.0 ± 2.4 
67.5 ± 5.9 / 
-7.9 ± 3.6 
 
Pierce et 
al.122 
LCD  
 
Control  
26 (15/11) 
 
14 (9/5) 
49.5 (2.5) 
 
40.8 (3.3) 
29 (1) 
 
31 (1) 
Individualized diet with pre-
set weight loss goal 
(minimum calories 1200 
kcal/day) 
12 CT L4-L5 
(cm²) 
128 (10) / 
84 (7) 
150 (19) / 
154 (19) 
85 (3) / 76(2) 
 
94 (3) / 95(3) 
Purnell et 
al.123 
LCD  21 (21/0) 65 (60-75) 31 (27-37) Restriction to 1200 kcal/day 13 CT umbilicus 
(cm²) 
201 ± 51 / 
153 ± 49 
96 ± 11 / 
86 ± 11 
Purnell et 
al.124 
LCD  
 
 
13 (5/8) NR 35 ± 4.8 Restriction to 1000 kcal/day 
for 3 months, thereafter 
gradual transition during 2 
weeks to a solid diet 
13 CT umbilicus 
(cm²) 
146 ± 57 / 
77 ± 47 
 99 (no SD) / 
82 
Riches et 
al.125 
LCD  
 
Isocaloric diet  
12 (12/0) 
 
14 (14/0) 
NR 34.1 (1.0) 
 
34.6 (0.7) 
Restriction to 1200 kcal/day 
 
 
14 MRI L3 (cm²) 322.8 (23.4) / 
222.1 (22.1) 
309.6 (20.3) / 
296.7 (15.1) 
106.3 (4.1) / 
95.9 (4.0) 
108.2 (2.4) / 
109.1 (2.6) 
Ross et 
al.26 
LCD  11 (11/0) 46.8 ± 7.6 31.6 ± 2.7 Reduction of 1000 kcal/day 16 MRI (l) 4.7 ± 1.6 / 
-1.5 ± 0.8 
Only %loss 
-11.5% 
Rossi et 
al.126 
LCD  24 (13/11) 46.7 ± 14.3 35.4 ± 4.5 Reduction of 500 kcal below 
daily energy expenditure 
13-26 MRI L4-L5 
(cm²) 
174.8 ± 94.7 / 
118.9 ± 76.3 
98.4 ± 15.9 / 
89.7 ± 14.8 
Ryan et 
al.127 
LCD  in NGT  
 
29 (0/29) 
 
60 (1) 
 
32.8 (0.9) 
 
Reduction of 500 kcal/day 26 CT L4-L5 146.9 (12.6) / 
127.1 (11.1) 
88.3 (2.8) / 
81.9 (2.9) 
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LCD in IGT  17 (0/17) 65 (2) 32.7 (1.2) (cm² 148.7 (11.6) / 
126.5 (9.7) 
84.4 (3.7) / 
77.0 (3.3) 
Reference Groups N (M/F) Age (years) BMI (kg/m²) Caloric restriction Duration 
(weeks) 
Assessment 
VAT 
Results VAT 
(pre / post) 
Weight (kg) 
(pre/post) 
Ryan et 
al.128 
LCD  
 
23 (0/23) 56 (1) Range: 25-
48 
Reduction of 250-350 
kcal/day 
26 CT L4-L5 
(cm²) 
140.4 (12.1) / 
115.1 (11.5) 
88.8 (3.8) / 
83.6 (3.7) 
Saiki et 
al.129 
LCD  22 (16/6) 53.6 ± 8.4 30.4 ± 5.3 Restriction to 740 or 970 
kcal/day 
4 CT L4-L5 
(cm²) 
233.1 ± 66.5 / 
191.0 ± 67.0 
85.2 ± 17.0 
79.0 ± 17.2 
Shin et 
al.130 
LCD in MAO  
 
LCD in MHO  
106 (0/106) 
23 (0/23) 
39.8 ± 12.2 
 
36.4 ± 11.2 
28.0 ± 2.6 
 
27.2 ± 1.94 
Reduction of 300 kcal/day 12 CT L4 (cm²) 95.1 ± 34.0 / 
89.5 ± 33.4 
69.0 ± 18.5 / 
63.6 ± 15.5 
71.2 ± 8.3 / 
-3.16±4.08% 
70.5 ±5.1 / 
-2.83±2.74% 
Snel et 
al.131 
VLCD  14 (8/6) 53 (2) 35.2 (1.1) Restriction to 450 kcal/day 16 MRI L5 (ml) 553 (47) / 
228 (46) 
107 (4) /  
83 (4) 
Stallone et 
al.132 
LCD  11 (0/11) 52 (no SD) 37.0 ± 4.5 3 months restriction 400-800 
kcal/day, 2 months refeeding, 
1 month 1200-1500 kcal/day 
26 CT L4 (cm²) 148 ± 75.4 / 
-52.9 ± 38.0 
94.8 ± 10.8 / 
-18.8 ± 6.9 
Svendsen 
et al.133 
VLCD  10 (0/10) Median 
(range) 
34 (28-27)  
NR(minimum 
for each 
subject: 28) 
Restriction to 500-600 
kcal/day 
8 CT umbilicus 
(cm²) 
125.9 ± 115.2 / 
109.8 ± 90.3 
Only %loss: 
-11% 
Tchernof 
et al.134 
LCD  25 (0/25) 57.2 ± 5.5 35.3 ± 4.0 Restriction to 1200 kcal/day 13.9 CT L4-L5 
(cm²) 
202 ± 73 / 
128 ± 57 
93.0 ± 10.7 / 
79.5 ± 11.0 
Tiikainen 
et al.135 
Women with high 
liver fat  
Women with low liver 
fat  
11 (0/11) 
 
12 (0/12) 
37 (1) 
 
37 (2) 
33 (1) 
 
32 (10) 
Reduction of 600-800 
kcal/day 
18-19 MRI (cm³) 1665 ± 141 / 
-383 ± 67 
1497 ± 167 / 
-441 ± 122 
Only %loss: 
-8.4 (0.2)% 
-8.3 (0.2)% 
Toledo et 
al.136 
LCD  
 
7 (3/7) 
 
46.1 (2.0) 
 
 
33.4 (1.2) Reduction of 25% of calorie 
intake (both groups) 
19.2 CT L4-L5 
(cm²) 
207.9 (24.7) / 
172.1 (32) 
95.0 (4.3) / 
84.4 (2.7) 
Van Dam 
et al.137 
VLCD in ovalutory 
responders  
VLCD in ovalutory 
non-responders  
 
9 (0/9) 
 
6 (0/6) 
30 (2.5) 
 
30 (1.8) 
37.5 (1.6) 
 
41.9 (3.6) 
Restriction to 470 kcal/day  8 MRI L4-L5 
(cm²) 
138 (17) / 
91 (18) 
166 (29) / 
114 (217) 
NR 
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Reference Groups N (M/F) Age (years) BMI (kg/m²) Caloric restriction Duration 
(weeks) 
Assessment 
VAT 
Results VAT 
(pre / post) 
Weight (kg) 
(pre/post) 
Van der 
Kooy et 
al.138 
Obese women 
 
Obese men  
40 (0/40) 
 
38 (38/0) 
39 ± 6 
 
40 ± 6 
31.3 ± 2.3 
 
30.7 ± 2.3 
Reduction of 1000 kcal/day 13 MRI (cm²) 106 ± 50 / 
-37 ± 29 
154 ± 40 / 
-61 ± 25 
86.5 ± 8.7 / 
-12.6 ± 3.9 
98.3 ± 7.2 / 
-13.3 ± 3.0 
Viljanen et 
al.139 
VLCD  16 (4/12) 45 (2.5) 33.3 (1.1) Restriction to 550 kcal/day 6 MRI L2/L3 
(kg) 
1.6 (0.2) / 
1.2 (0.1) 
95.7 (3.3) / 
84.6 (2.9) 
Vissers et 
al.140 
LCD 
 
Control  
20 (5/15) 
 
21 (5/16) 
45.5 ± 13.1 
 
44.8 ± 11.4 
32.9 ± 3.1 
 
30.8 ± 3.4 
Reduction of -600 kcal/day 
(for all diet groups) 
26 CT L4-L5 
(cm²) 
134.8 ± 57.3 / 
-26/3 ± 29.2 
111.5 ± 47.6 / 
-3.6 ± 20.5 
92.1 ± 11.1 / 
- 6.1 ± 4.6 
88.6 ± 15.9 / 
+ 0.9 ± 3.4 
Wahlroos 
et al.141 
VLCD (n=13) 13 (0/13)  45 ± 7 Restriction to 450-800 
kcal/day 
6 MRI L4-L5 
(mm²) 
22400±11300/ 
18300±8700 
118.8 ± 16.6/ 
110.0 ± 17.5 
Weinsier 
et al.142 
LCD in white women 
 
LCD in black women 
 
23 (0/23) 
 
23 (0/23) 
37.0 ± 5.9 
 
35.5 ± 5.9 
29.0 ± 1.5 
 
28.7 ± 1.8 
Restriction to 800 kcal/day 22 CT L4-L5 
(cm²) 
113.0 ± 39.2 / 
67.0 ± 23.8 
67.6 ± 18.0 / 
41.8 ± 16.9 
79.1 ± 5.0 / 
66.0 ± 4.8 
78.2 ± 8.9 / 
65.6 ± 7.7 
Zamboni 
et al.143 
VLCD and LCD 16 (0/16) 38.8 ± 14.1 38.2 ± 6.9 First two weeks restriction to 
307 kcal/day (VLCD) 
LCD for a mean duration of 
14 weeks with restriction to 
1003 kcal/day 
16 CT L4 (cm²) 167 ± 80.3 / 
93.3 ± 61.6 
104.3 ± 18.1 
88.1 ± 11.6 
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Table 2. Characteristics of included studies (n=8) that directly compared exercise training with hypocaloric diet 
Reference Groups N (M/F) Age 
(years) 
BMI 
(kg/m²) 
Intensity (exercise 
studies) 
 
Caloric restriction 
(hypocaloric diet 
studies) 
Frequency/ 
duration per 
session (for 
exercise only) 
Duration 
(weeks) 
Assess 
ment 
VAT 
Results VAT 
(pre / post) 
Results 
weight (kg) 
(pre / post) 
Christian
sen et 
al.144 
Aerobic exercise 
 
LCD 
19 (9/10) 
 
19 (10/9) 
37.2 ± 7 
 
35.6 ± 7 
33.3 ± 4 
 
35.3 ± 4 
70% of HRR 
 
Restriction to 600 kcal 
during 8 weeks 
60-75 min per 
session, 3x/week 
12  
 
8 weeks 
diet, 4 
weeks 
weight 
mainte- 
nance 
MRI 3038.3±1086.1 / 
-18.4% ± 2.8 
3437.5±1516.2 / 
-30.2% ± 3.2 
 
100.9 / 
-3.5kg 
107.8 / 
-12.3 
 
Coker et 
al.145 
Aerobic exercise  
 
LCD  
 
 
 
 
 
Control  
6 (2/4) 
 
6 (3/3) 
 
 
 
 
 
5 (3/2) 
55 (2) 
 
58 (2) 
 
 
 
 
 
59 (2) 
32 (1) 
 
30 (0) 
 
 
 
 
 
31 (1) 
50% of VO2peak 
 
Reduction of 1000 
kcal/week in week 1, 
and a further addition 
of 500 kcal each week 
until a reduction of 
2500 kcal/week was 
reached 
Depending on 
energy 
expenditure 
(week 1: 1000 
kcal with a 
gradual increase 
to 2500 
kcal/week) 
12  CT (cm²) 245 (31) / 
228 (24) 
199  (12) / 
170 (11) 
 
 
 
 
198 (17)/ 
170 (11) 
91 (3) / 91 
(3) 
 
 
86 (2) / 81 
(2) 
 
 
89 (4) / 91 
(4) 
Koo et 
al.146 
LCD 
 
 
Aerobic exercise 
 
Control 
19 (0/19) 
 
 
13 (0/13) 
 
18 (0/18) 
57 ± 8 
 
 
59 ± 4 
 
57 ± 8 
27.1 (no 
SD) 
 
25.5  
 
28.5  
Restriction 1200 
kcal/day 
 
Depending on energy 
expenditure 
 
 
 
7 days/week, 120 
minutes 
12  CT L4-L5 
(cm²) 
157.8 / 151.7 
 
162.4 / 146.9 
 
 
172.4 /163.4 
 67.4 (no 
SD) / 
 62.4 
 
64.0 /  62.4 
 
66.0 / 65.8 
Nordby et 
al.147 
Aerobic training 
 
 
LCD 
 
12 (12/0) 
 
 
12 (12/0) 
 
28 (1) 
 
 
32 (2) 
 
28.3 (0.3) 
 
 
28.0 (0.4) 
 
65% HRR, alternated 
with HIIT (bouts at 
85% HRR) 
Reduction of 600 
kcal/day 
7 days/week, 
duration 
depended on 
energy 
expenditure (600 
12 MRI T11-
L5 (L) 
 
1.60 (0.12) / 
-0.53 
 
1.83 (0.18) / 
-0.25 
94.5 (2.3) / 
88.6 (2.3) 
 
91.2 (1.8) / 
85.9 (2.2)* 
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Control 12 (12/0) 31 (2) 28.0 (0.4) kcal per session) 2.12 (0.21) / 
-0.02 
92.2 (2.7) / 
92.1 (2.5) 
Reference Groups N (M/F) Age 
(years) 
BMI 
(kg/m²) 
Intensity (exercise 
studies) 
 
Caloric restriction 
(hypocaloric diet 
studies) 
Frequency/ 
duration per 
session (for 
exercise only) 
Duration 
(weeks) 
Assess 
ment 
VAT 
Results VAT 
(pre / post) 
Results 
weight (kg) 
(pre / post) 
Oh et 
al.148 
Aerobic exercise  
 
LCD  
108 
(108/0) 
104 
(104/0) 
NR 
(adults) 
29.2 (0.3) 
 
29.4 (0.4) 
60-85% of maxHR 
 
Restriction to 1680 
kcal/day 
3 days/week, 40-
60 minutes 
12 CT (cm²) 
 
178.1 (5.5) / 
156.4 (5.0 
159.0 (6.2) / 
123.3 (5.2) 
85.2 (1.0) / 
82.6 (1.0) 
84.9 (1.3) / 
77.7 (1.2) 
Racette et 
al.149 
LCD  
 
 
 
Aerobic exercise  
 
 
 
Control  
19 (7/12) 
 
 
 
19 (7/12) 
 
 
 
10 (4/6) 
55.6 (0.8) 
 
 
 
58.8 (0.6) 
 
 
 
56.0 (0.9) 
27.2 (0.6) 
 
 
 
27.2 (0.4) 
 
 
 
27.9 (0.4) 
Reduction of 16% of 
caloric intake 3 
months, reduction of 
20% 9 months 
Depending on energy 
deficit (same reduction 
as diet groups) 
7 days /week, 
duration 
depending on 
energy deficit 
52 MRI (cm³) 824.7 ± 143,4 / 
633.5 ± 95.6 
 
 
1123.5 ± 131.5 / 
513.9 ± 107.6 
 
 
1159.4 ± 203.4 / 
1004 ± 155 
78.5 (2.3) / 
70.5 (2.3) 
 
 
77.5 (2.4) / 
71.0 (2.4) 
 
 
81.9 (3.7) / 
80.0 (3.7) 
Ross et 
al.150 
LCD 
 
Aerobic exercise 
 
Control  
15 (0/15) 
 
17 (0/17) 
 
10 (0/10) 
43.9 ± 4.9 
 
43.2 ± 5.1 
 
43.7 ± 6.4 
 
31.9 ± 2.8 
 
32.8 ± 3.9 
 
32.4 ± 2.8 
Reduction of 500 
kcal/day 
~80% maxHR 
7 days/week, 63 
minutes 
14 MRI (kg) 2.4 ± 1.2 / 
1.9 ± 1.0 
2.3 ± 0.8 / 
1.6 ± 0.7 
2.3 ± 0.9 / 
2.2 ± 0.9 
86.6 ± 10.9/ 
80.1 ± 11.2 
86.8 ± 10.9/ 
80.9 ± 10.8 
88.1 ± 8.2 / 
88.6 ± 7.4 
Ross et 
al.151 
LCD 
 
Aerobic exercise 
 
Control 
14 (14/0) 
 
16 (16/0) 
 
8 (8/0) 
42.6 ± 9.7 
 
45.0 ± 7.5 
 
46.0±10.9 
30.7 ± 1.9 
 
32.3 ± 1.9 
 
30.7 ± 1.6 
Reduction of 700 
kcal/day 
~75% max HR 
7 days per week, 
60.4 minutes 
14 MRI L4-
L5 (kg) 
3.2 ± 1.0 / 
-25.2 (2.0)% 
3.9 ± 1.0 / 
-27.5 (1.9)% 
4.1 ± 1.7 / 
-1.9 (2.7)% 
96.1 ± 8.7 / 
-7.7 (0.2)% 
101.5±7.7 / 
-7.5 (0.3)% 
96.7 ± 9.0 / 
-0.2 (0.4)% 
Data depicted as: Mean ± standard deviation or Mean (standard error). Post value –(x) represents absolute decrease in VAT or weight (unless stated otherwise). 
Abbreviations: M=male; F=female; BMI=body mass index; NR= not reported; maxHR = maxium heart rate; HRR = heart rate reserve; min = minutes; CT = Computed Tomography; MRI = magnetic 
resonance imaging; LCD=low calorie diet 
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